Clinical Trial Update: The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis

View source ↗

Summary

A completed clinical trial evaluated whether levetiracetam (Keppra) reduces tremor in patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Multiple Sclerosis | Status: COMPLETED